ClinicalTrials.gov record
Completed Phase 3 Interventional

Phase 3 Efficacy and Safety Study of Favipiravir for Treatment of Uncomplicated Influenza in Adults - T705US316

ClinicalTrials.gov ID: NCT02026349

Public ClinicalTrials.gov record NCT02026349. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 7:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Favipiravir in Adult Subjects With Uncomplicated Influenza (T705US316)

Study identification

NCT ID
NCT02026349
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
MDVI, LLC
Industry
Enrollment
860 participants

Conditions and interventions

Conditions

Interventions

  • Placebo Drug
  • favipiravir Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2013
Primary completion
Feb 28, 2015
Completion
Feb 28, 2015
Last update posted
Nov 10, 2015

2014 – 2015

United States locations

U.S. sites
60
U.S. states
19
U.S. cities
51
Facility City State ZIP Site status
Not listed Birmingham Alabama 06117
Not listed Birmingham Alabama 35209
Not listed Hunstville Alabama 35801
Not listed Hot Springs Arkansas 71913
Not listed Los Angeles California 90017
Not listed Los Angeles California 90020
Not listed Orange California 92866
Not listed Sacramento California 95825
Not listed San Diego California 92120
Not listed San Diego California 92128
Not listed Tustin California 92780
Not listed Upland California 91786
Not listed Colorado Springs Colorado 80904
Not listed Hamden Connecticut 65140
Not listed Bradenton Florida 34205
Not listed Brooksville Florida 34601
Not listed Gainesville Florida 32605
Not listed Gainesville Florida 32607
Not listed Hialeah Florida 33012
Not listed Hialeah Florida 33016
Not listed Lakeland Hills Florida 33805
Not listed Miami Florida 33126
Not listed Miami Florida 33135
Not listed Miami Florida 33137
Not listed Miami Florida 33173
Not listed Saint Cloud Florida 34769
Not listed South Miami Florida 33143
Not listed St. Petersburg Florida 33709
Not listed Tampa Florida 33606
Not listed Atlanta Georgia 30312
Not listed Snellville Georgia 30039
Not listed Bardstown Kentucky 40004
Not listed Monroe Louisiana 71201
Not listed Opelousas Louisiana 70570
Not listed Flint Michigan 48504
Not listed Omaha Nebraska 68114
Not listed Las Vegas Nevada 89121
Not listed Hickory North Carolina 28601
Not listed Morganton North Carolina 28655
Not listed Winston-Salem North Carolina 27103
Not listed Lansdale Pennsylvania 19446
Not listed Pittsburgh Pennsylvania 15236
Not listed Smithfield Pennsylvania 15478
Not listed Uniontown Pennsylvania 15401
Not listed Gaffney South Carolina 29341
Not listed Greenville South Carolina 29615
Not listed Greer South Carolina 29651
Not listed Simpsonville South Carolina 29681
Not listed Arlington Texas 76012
Not listed Austin Texas 78756
Not listed Carrollton Texas 75010
Not listed Forth Worth Texas 76104
Not listed Houston Texas 77062
Not listed Plano Texas 75093
Not listed San Antonio Texas 78207
Not listed Salt Lake City Utah 84109
Not listed Salt Lake City Utah 84121
Not listed South Jordan Utah 84095
Not listed Arlington Virginia 22203
Not listed La Crosse Wisconsin 54601

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 165 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02026349, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 10, 2015 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02026349 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →